When you need an exception (vs a PA)
Use the right tool for your denial:
Prior authorization
The drug IS covered, but you must meet criteria (BMI, lifestyle documentation, etc.). See the GLP-1 PA pillar.
Formulary exception
The drug is non-preferred or non-formulary, and you need it over the covered alternatives — a medical-necessity request.
Neither will work
The plan flatly excludes weight-loss drugs — that's a benefit exclusion an exception can't override.
How to make the case
A strong exception request, submitted by your prescriber, documents that the plan's preferred alternatives were tried and failed, caused intolerable side effects, or are contraindicated for you — and explains why the requested GLP-1 is appropriate. Where relevant, cite the specific FDA indication (cardiovascular risk with Wegovy, or sleep apnea with Zepbound). If the exception is denied, you can appeal.
The three exception types — ask for the right one
“Formulary exception” is used loosely to mean three different requests. Naming the right one saves a round trip:
| Ask for this | When | What it gets you |
|---|---|---|
| Formulary exception | The drug is not on the formulary at all | Coverage of a non-listed drug |
| Tiering exception | It is covered, but at a costly tier | The same drug at lower cost-sharing |
| Step-therapy exception | You are required to try another drug first | Skipping the required trial |
One caveat worth knowing before you spend effort: tiering exceptions are commonly unavailable for drugs on a plan's specialty tier. Check your plan's rules on that point first.
What the supporting statement must actually assert
The prescriber's supporting statement is the request. Without it, nothing moves — and it is the most common reason an exception stalls. It should state, in the plan's own terms:
- Which preferred alternatives were tried — named, with doses and dates.
- What happened — inadequate response, or a specific adverse effect, documented when it occurred rather than recalled afterward.
- Or why they cannot be tried — contraindication, interaction, or a condition that rules them out.
- Why the requested drug is appropriate, tied to its FDA-approved indication where one applies.
- For a tiering exception: that the lower-tier alternatives would be ineffective or harmful for you specifically.
“Patient prefers this drug” is not a medical-necessity argument, and reviewers discard it. Everything above should be a fact with a date attached.
Medicare Part D timing: the numbers that are set in regulation
If you are on Part D, the clock is federal, not plan-specific. The plan must decide a standard request within 7 calendar days and an expedited one within 72 hours; a payment-reimbursement request gets 14 days. If they miss the deadline, that counts as a denial and the plan must forward your case to the Independent Review Entity within 24 hours — you do not refile.
The exception-specific trap: at the Independent Review Entity level, if your prescriber's supporting statement has not arrived, the review can be extended by up to 14 days waiting for it. The statement is the bottleneck at every level. Confirm it was sent, and get a copy for your own records.
Sources: 42 CFR 423.590 and 423.600. Full ladder and deadlines: GLP-1 denial appeal.
Exception processes and timeframes vary by plan type (commercial, Medicare Part D, Medicaid). This is general guidance as of 2026-07-18, not legal or insurance advice — check your plan's documents.